Class action lawsuits have been filed against Gossamer Bio, New Era Energy, and Medpace Holdings, accusing them of making false or misleading statements and failing to disclose adverse facts about their businesses. The lawsuits claim these companies misrepresented clinical trial results, regulatory progress, and financial projections, leading to investor losses. Deadlines for investors to file lead plaintiff motions are in early June 2026. Affected shareholders are encouraged to contact legal counsel to explore their rights and potential claims.

More News (MEDP)

Osteosarcoma drug pipeline grows with 25+ companies developing 32+ therapies including Phase III ADC and CAR-T treatments

The osteosarcoma treatment pipeline features over 25 companies developing more than 32 drugs, highlighting strong R&D activity in this bone cancer field. Key drugs in late-stage trials include HS-20093, an antibody-drug conjugate targeting B7-H3, and...

Others

Bullish

3 days ago

Class action lawsuits filed against Gossamer Bio, New Era Energy, and Medpace Holdings for misleading investors.

More News (MEDP)

Osteosarcoma drug pipeline grows with 25+ companies developing 32+ therapies including Phase III ADC and CAR-T treatments

Invest & Trade with
#1 Award-Winning Investment Super App

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store

Class action lawsuits filed against Gossamer Bio, New Era Energy, and Medpace Holdings for misleading investors.

More News (MEDP)

Osteosarcoma drug pipeline grows with 25+ companies developing 32+ therapies including Phase III ADC and CAR-T treatments

Invest & Trade with#1 Award-Winning Investment Super App

iOS App Store

Google Play Store

Invest & Trade with
#1 Award-Winning Investment Super App